REGENXBIO
Business Services · Maryland, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
9804 Medical Center Dr, Rockville, Maryl...Phone Number
(240) 552-8181Website
www.regenxbio.comRevenue
$170.4 MillionStock Symbol
RGNXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
3
1
1
About REGENXBIO
REGENXBIO Inc. is a clinical-stage biotechnology company. It specializes in providing gene therapy product. The company was founded in 2008 and is headquartered in Rockville, Maryland.Explore more
REGENXBIO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is REGENXBIO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once REGENXBIO has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at REGENXBIO
Earning: See what the market has to say on REGENXBIO recently announced quarterly report
Check if REGENXBIO has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when REGENXBIO launches new products
Click to see if REGENXBIO had a recent Job posting/layoffs
REGENXBIO, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if REGENXBIO is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to REGENXBIO
Compare insights from companies similar to REGENXBIO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
REGENXBIO is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
REGENXBIO is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about REGENXBIO.
REGENXBIO financials insights
Gather financial insights about REGENXBIO, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$138.6M
REGENXBIO Tech Stack
A closer look at the technologies used by REGENXBIO
See more technologies
Most Recent Scoops
Person-Based
Governmental Affairs & Regulation, Regulations
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Pharmaceuticals
Person-Based
Governmental Affairs & Regulation, Regulations
REGENXBIO News & Media
REGENXBIO to Participate in Upcoming Investor Conferences
ROCKVILLE, Md., May 18, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences: 2026 RBC Capital Markets Global Healthcare Conference Fireside Chat: Wednesday, May 20 at 9:30am ET Location: New York, NY Stifel 2026...REGENXBIO Inc. (RGNX) Q1 2026 Earnings Call Transcript
REGENXBIO Inc. (RGNX) Q1 2026 Earnings Call May 14, 2026 8:00 AM EDTCompany ParticipantsPatrick Christmas - Executive VP & Chief Strategy and Legal...REGENXBIO Reports First Quarter 2026 Financial Results and Operational Highlights
Company announced positive topline results from pivotal Phase III AFFINITY DUCHENNE® study of RGX-202 Primary endpoint achieved with high statistical significance Statistically significant correlation between RGX-202 microdystrophin expression and functional improvement (NSAA, n=9),...REGENXBIO Announces Positive Topline Results from Pivotal Phase III AFFINITY DUCHENNE® Study of RGX-202
Achieved primary endpoint with high statistical significance; 93% of patients achieved microdystrophin expression above 10% (p<0.0001) Statistically significant correlation between RGX-202 microdystrophin expression and functional improvement (NSAA n=9), supporting validity of surrogate...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding REGENXBIO
Sign Up For FreeTo access detailed company insights
REGENXBIO Inc. is a clinical-stage biotechnology company. It specializes in providing gene therapy product. The company was founded in 2008 and is headquartered in Rockville, Maryland.... Read More
